Liver Diseases; Liver Failure; Liver Neoplasms; Liver Neoplasms, Experimental
I´m a surgical oncologist with special training in hepatobiliary surgery to treat benign and malignant diseases of the liver, gallbladder and bile duct. This encompasses a wide spectrum of diseases such as cancer, cysts and lesions, gallstones, stricture and bile leaks. My main research interest is to assess the impact of neoadjuvant chemotherapy on patients with colorectal cancer liver metastases on liver function and clinical outcome after liver resection. A further research focus is safety of liver resection for HCC (Hepatocellular Carcinoma) in patients with portal hypertension defined as 90 days postoperative morbidity and mortality and to find new predictive markers for liver decompensation.
Techniques, methods & infrastructure
Prospective randomized trials are used to answer clinical relevant questions on liver regeneration and dysfunction in patients after LR and to evaluate the significance of neoadjuvant chemotherapy or portal hypertension on the post-operative course of the patient. A broad spectrum of biochemica and imaging techniques are used.